BUZZ-Indian pharma stocks set for worst day in 2 years on Trump tariff woes

Indian pharma stocks .NIPHARM shed 3.1%, set for worst day since late February 2022; benchmark Nifty 50 .NSEI drops 0.8%

API maker Laurus Labs LAUL.NS top pct loser on index with 9.3% decline

Sun Pharma SUN.NS, India's top drugmaker by rev, Dr Reddy's REDY.NS decline ~3% each, Cipla CIPL.NS falls 1%

U.S. President Donald Trump is devising plans for reciprocal tariffs on every country, however the imposition of duties is likely to be delayed

Analysts say India expected to be among worst hit by reciprocal tariffs

Drop in pharma stocks shows investors are extremely jittery over uncertainties around quantum of tariffs that Trump will impose on pharma imports from India, says Shrikant Akolkar, analyst, Nuvama Institutional Equities

Indian drugmakers derive significant chunk of revenue from U.S.

"Uncertainty over continued USAID funding is also weighing on investors' sentiment," Akolkar says